CHART SMART: Documenting an adverse drug reaction

October 2005 
Volume 35  Number 10
Pages 22 - 22
  PDF Version Available!


PROPERLY CHARTING a patient's adverse drug reaction (ADR) can protect him from further harm and shield you and your facility from legal problems. But documenting ADRs has wider implications too: Because a significant part of the evaluation for any drug's long-term safety occurs after it's on the market, serious ADRs should be reported to the Food and Drug Administration's (FDA's) MedWatch program.

If you suspect an ADR, care for the patient, then notify the prescriber. If the ADR is serious, stay with the patient and have a colleague notify the prescriber. Document the patient's clinical condition, your interventions, and the patient's response. When the patient is stable, inform your supervisor, pharmacist, and risk manager if the ADR was serious. Depending on facility and state health department policies, you may also need to notify the patient or family. Fill out an incident report and internal ADR report, which should contain all the information ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.

Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.

Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events